32
Pharma & HealthcareAvoid
LIC MF Healthcare
LIC · Direct–Growth · rank #16 of 18 by Smart Score
Data updated
Trailing returns
1 Year
19.3%
+16.3% vs index
3 Years
23.7%
+12.1% vs index
5 Years
12.7%
+2.3% vs index
Since launch
19.5%
Year-by-year performance
2024
+43.9%+28.3% vs index
2025
-3.2%-10.9% vs index
2026
+18.8%+20.9% vs index
Why this score
LIC MF Healthcare scores 32/100 — #16 of 18 Pharma & Healthcare fund (Avoid). It stands out for 3y return — beating 68% of peers on 3y return. The main drag is its 5y return (better than only 6% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
5Y return12.69% · 6th percentile in category
Fund size97.66 Cr · 3rd percentile in category
Expense ratio1.42% · 8th percentile in category
3Y return23.72% · 68th percentile in category
Alpha2.64 · 9th percentile in category
Volatility16.39 · 34th percentile in category
Top holdings
1.Sun Pharmaceutical Industries Ltd10.69%
2.Divi's Laboratories Ltd9.47%
3.Torrent Pharmaceuticals Ltd6.89%
4.Apollo Hospitals Enterprise Ltd6.62%
5.Neuland Laboratories Ltd5.57%
22 disclosed equity positions · portfolio as of Jul 2026 · weights are % of total corpus.